Aktiengesellschaft Bayer - Net Worth and Insider Trading
Aktiengesellschaft Bayer Net Worth
The estimated net worth of Aktiengesellschaft Bayer is at least $569 Million dollars as of 2025-04-25. Aktiengesellschaft Bayer is the 10% Owner of IPSCO Tubulars Inc and owns about 12,675,838 shares of IPSCO Tubulars Inc (IPSC) stock worth over $391 Million. Aktiengesellschaft Bayer is the 10% Owner of Elanco Animal Health Inc and owns about 18,446,429 shares of Elanco Animal Health Inc (ELAN) stock worth over $175 Million. Aktiengesellschaft Bayer is also the 10% Owner of CRISPR Therapeutics AG and owns about 75,945 shares of CRISPR Therapeutics AG (CRSP) stock worth over $3 Million. Details can be seen in Aktiengesellschaft Bayer's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Aktiengesellschaft Bayer has not made any transactions after 2021-06-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Aktiengesellschaft Bayer
Aktiengesellschaft Bayer Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Aktiengesellschaft Bayer owns 6 companies in total, including Elanco Animal Health Inc (ELAN) , CRISPR Therapeutics AG (CRSP) , and Pyxis Oncology Inc (PYXS) among others .
Click here to see the complete history of Aktiengesellschaft Bayer’s form 4 insider trades.
Insider Ownership Summary of Aktiengesellschaft Bayer
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| ELAN | Elanco Animal Health Inc | 2020-12-03 | 10 percent owner |
| CRSP | CRISPR Therapeutics AG | 2018-01-05 | 10 percent owner |
| PYXS | Pyxis Oncology Inc | 2021-10-07 | 10 percent owner |
 | | 2021-06-17 | 10 percent owner |
| | 2022-06-08 | 10 percent owner |
| | 2023-06-15 | 10 percent owner |
Aktiengesellschaft Bayer Latest Holdings Summary
Aktiengesellschaft Bayer currently owns a total of 3 stocks. Among these stocks, Aktiengesellschaft Bayer owns 12,675,838 shares of IPSCO Tubulars Inc (IPSC) as of June 22, 2021, with a value of $391 Million and a weighting of 68.8%. Aktiengesellschaft Bayer owns 18,446,429 shares of Elanco Animal Health Inc (ELAN) as of December 3, 2020, with a value of $175 Million and a weighting of 30.67%. Aktiengesellschaft Bayer also owns 75,945 shares of CRISPR Therapeutics AG (CRSP) as of January 5, 2018, with a value of $3 Million and a weighting of 0.52%.
Latest Holdings of Aktiengesellschaft Bayer
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| IPSC | IPSCO Tubulars Inc | 2021-06-22 | 12,675,838 | 30.88 | 391,429,877 |
| ELAN | Elanco Animal Health Inc | 2020-12-03 | 18,446,429 | 9.46 | 174,503,218 |
| CRSP | CRISPR Therapeutics AG | 2018-01-05 | 75,945 | 39.11 | 2,970,209 |
Holding Weightings of Aktiengesellschaft Bayer
Aktiengesellschaft Bayer Form 4 Trading Tracker
According to the SEC Form 4 filings, Aktiengesellschaft Bayer has made a total of 1 transactions in IPSCO Tubulars Inc (IPSC) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in IPSCO Tubulars Inc is the acquisition of 750,000 shares on June 22, 2021, which cost Aktiengesellschaft Bayer around $15 Million.
According to the SEC Form 4 filings, Aktiengesellschaft Bayer has made a total of 1 transactions in Elanco Animal Health Inc (ELAN) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Elanco Animal Health Inc is the sale of 54,500,000 shares on December 3, 2020, which brought Aktiengesellschaft Bayer around $1.6 Billion.
According to the SEC Form 4 filings, Aktiengesellschaft Bayer has made a total of 0 transactions in CRISPR Therapeutics AG (CRSP) over the past 5 years. The most-recent trade in CRISPR Therapeutics AG is the acquisition of 527,472 shares on January 5, 2018, which cost Aktiengesellschaft Bayer around $12 Million.
Insider Trading History of Aktiengesellschaft Bayer
- 1
Aktiengesellschaft Bayer Trading Performance
GuruFocus tracks the stock performance after each of Aktiengesellschaft Bayer's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Aktiengesellschaft Bayer is 59.16%. GuruFocus also compares Aktiengesellschaft Bayer's trading performance to market benchmark return within the same time period. The performance of stocks bought by Aktiengesellschaft Bayer within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Aktiengesellschaft Bayer's insider trading performs compared to the benchmark.
Performance of Aktiengesellschaft Bayer
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 32.9 | | | | | |
| Relative Return to S&P 500(%) | 36.33 | | | | | |
Aktiengesellschaft Bayer Ownership Network
Ownership Network List of Aktiengesellschaft Bayer
Ownership Network Relation of Aktiengesellschaft Bayer
Aktiengesellschaft Bayer Owned Company Details
What does Elanco Animal Health Inc do?
Who are the key executives at Elanco Animal Health Inc?
Aktiengesellschaft Bayer is the 10 percent owner of Elanco Animal Health Inc. Other key executives at Elanco Animal Health Inc include director & Pres. & Chief Executive Officer Jeffrey N Simmons , EVP & MANUFACTURING AND QUALITY Grace Mcardle , and See remarks Timothy J Bettington .
Elanco Animal Health Inc (ELAN) Insider Trades Summary
Over the past 18 months, Aktiengesellschaft Bayer made no insider transaction in Elanco Animal Health Inc (ELAN). Other recent insider transactions involving Elanco Animal Health Inc (ELAN) include a net purchase of 45,000 shares made by R David Hoover , a net purchase of 30,000 shares made by William F Doyle , and a net purchase of 6,600 shares made by Michael J Harrington .
In summary, during the past 3 months, insiders sold 0 shares of Elanco Animal Health Inc (ELAN) in total and bought 45,000 shares, with a net purchase of 45,000 shares. During the past 18 months, 0 shares of Elanco Animal Health Inc (ELAN) were sold and 201,600 shares were bought by its insiders, resulting in a net purchase of 201,600 shares.
Elanco Animal Health Inc (ELAN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Elanco Animal Health Inc Insider Transactions
Aktiengesellschaft Bayer Mailing Address
Above is the net worth, insider trading, and ownership report for Aktiengesellschaft Bayer. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Aktiengesellschaft Bayer's mailing address is: Leverkusen 2m D-51368.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
